Glaxo Smith Kline News - Mubasher Info
KSA
Mubasher TV
 Contact Us Advertising   العربية
KSA
TDWL Closed
23 July 05:16 PM

Glaxo Smith Kline (BIOC)

Last update: 01:29 PM market time.
44.22
-0.18
-0.41%
Open 44.40
Previous Close 44.40
High 44.97
Low 43.40
Stock Statistics
Volume 139,372
Turnover 6,129,979.50
All data are 15 minutes late during market session

News

Photo Archive
19 November 2024 04:31 PM GSK Egypt posts EGP 106m consolidated profits in 9M-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) registered an annual growth in consolidated net profit after tax to EGP 105.82 million during the first nine months (9M) of 2024, versus EGP 46.73 million. The company generated net sales valued at EGP …
Financial Results
Photo Archive
19 August 2024 03:22 PM GSK Egypt’s net profits hike in H1-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) posted consolidated net profits amounting to EGP 92.55 million in the first half (H1) of 2024, versus EGP 19.57 billion in H1-23. Net revenues reached EGP 1.35 billion in H1-24, higher year-on-year …
Financial Results
Photo Archive
15 May 2024 11:22 AM GSK Egypt turns to loss in Q1-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) turned to a consolidated net loss of EGP 8.98 million in the first quarter (Q1) of 2024, versus a net profit of EGP 13.81 million in the corresponding quarter a year earlier. Consolidated net sales …
Financial Results
Photo Archive
30 April 2024 10:08 AM GSK Egypt obtains shareholders’ nod for 2023 cash dividends
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) plans to disburse cash dividends valued at EGP 0.75 per share for 2023, according to a bourse filing. The board members greenlighted the cash dividends last March, while the shareholders granted their …
Cash Dividends
Photo Archive
4 March 2024 06:01 PM GSK Egypt’s consolidated profits plunge to EGP 60m in 2023; dividends approved
Cairo – Mubasher: GlaxoSmithKline’s (GSK Egypt) consolidated net profit plunged to EGP 60.47 million in 2023 from EGP 735.39 million a year earlier. Consolidated net sales soared to EGP 2.24 billion last year from EGP 1.82 billion in 2022, …
Financial Results
Photo Archive
19 November 2023 10:41 AM GSK Egypt records plunge in 9M-23 profits; sales hit EGP 1.57bn
Cairo – Mubasher: The consolidated net profits after tax of GlaxoSmithKline (GSK Egypt) plummeted to EGP 46.72 million in the first nine months (9M) of 2023 from EGP 920.71 million in 9M-22. Net sales amounted to EGP 1.57 billion in …
Financial Results
Photo Archive
16 August 2023 09:50 AM GSK Egypt’s net profits shrink in H1-23 results
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) achieved consolidated net profits worth EGP 19.57 million in the first half (H1) of 2023, an annual plunge from EGP 871.81 million, including minority interest. As for the standalone business, the net …
Financial Results
Photo Archive
1 June 2023 05:35 PM GSK Egypt generates lower consolidated profits in Q1-23
Cairo – Mubasher: The consolidated net profits after tax of GlaxoSmithKline (GSK Egypt) plummeted to EGP 13.81 million in the first quarter (Q1) of 2023 from EGP 869.16 million in Q1-22, including minority interest. Net sales amounted to EGP …
Financial Results
Photo Archive
4 May 2023 10:38 AM GSK Egypt’s shareholders approve 2022 cash dividends
Cairo – Mubasher: The shareholders of GlaxoSmithKline (GSK Egypt) greenlighted a cash dividend distribution valued at EGP 0.75 per share for 2022. The EGX-listed firm will pay out the announced dividends once liquidity is available, according to a …
Cash Dividends
Photo Archive
3 April 2023 00:30 PM GSK Egypt records 376% leap in 2022 consolidated profits; dividends announced
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) witnessed 376% higher consolidated net profits after tax at EGP 735 million in 2022, compared to EGP 155 million in 2021. The revenues hit EGP 1.81 billion in January-December 2022, up 79% year-on-year …
Board of Directors
Photo Archive
30 November 2022 00:24 PM GSK Egypt sees surge in 9M-22 consolidated profits
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) logged EGP 920.72 million in consolidated net profits in the first nine months (9M) of 2022, compared to EGP 70.11 million in the prior-year period. The company’s sales amounted to EGP 1.16 billion …
Financial Results
Photo Archive
17 November 2022 03:04 PM GSK Egypt posts higher standalone profits at EGP 930m in 9M-22
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) logged standalone net profits after tax worth EGP 929.74 million in the first nine months (9M) of 2022, higher than EGP 89.83 million in 9M-21. Net sales enlarged to EGP 1.26 billion in …
Financial Results
Photo Archive
31 August 2022 11:23 AM GSK Egypt’s profits climb to EGP 872m in H1-22
Cairo - Mubasher: The consolidated net profits of GlaxoSmithKline (GSK Egypt) surged to EGP 871.81 million during the first half (H1) of 2022, compared to EGP 20.65 million in the same period in 2021. Revenues of the EGX-listed firm reached EGP …
Financial Results
Photo Archive
14 June 2022 02:47 PM GSK Egypt's consolidated profits skyrocket in Q1-22
Cairo - Mubasher: The consolidated net profits of GlaxoSmithKline (GSK Egypt) jumped to EGP 869.16 million in the first quarter (Q1) of 2022, compared to EGP 2.69 million in the year-ago period, including minority shareholders' rights. The company …
Financial Results
Photo Archive
1 June 2022 11:28 AM GSK Egypt's standalone profits hike in Q1-22
Cairo - Mubasher: GlaxoSmithKline (GSK Egypt) reported a surge in its standalone net profits to EGP 870.42 million in the first quarter (Q1) of 2022, compared to EGP 22.21 million in the year-ago period. The company generated revenues of …
Financial Results
Photo Archive
15 May 2022 04:57 PM GSK Egypt's profits skyrocket 454% in 2021; dividends proposed
Cairo - Mubasher: The unaudited consolidated financials of GlaxoSmithKline (GSK Egypt) reported a 454% surge in net profits to EGP 155 million in 2021 from EGP 28 million in 2020. The company's sales retreated by 9% to EGP 1.81 billion in 2021, …
Financial Results
Photo Archive
20 February 2022 01:38 PM GSK Egypt's EGM approves to sell EGP 1.18bn consumer healthcare assets
Cairo – Mubasher: The extraordinary general meeting (EGM) of GlaxoSmithKline (GSK Egypt) has approved to sell intangible and movable consumer healthcare assets, excluding real estate and machinery. The independent financial advisor Grant Thornton …
Companies Investments
The independent financial advisor valued these assets at EGP 1.179 billion
20 October 2021 11:45 AM GSK Egypt approves valuation report for consumer healthcare assets
Cairo – Mubasher: The board of directors of GlaxoSmithKline (GSK Egypt) approved a fair value (FV) report prepared by the independent financial advisor Grant Thornton - Egypt for the consumer health business assets. These assets include the …
Company News
The net sales tumbled to EGP 755.34 million in the January-June period
11 August 2021 05:34 PM GSK Egypt's profit slides 82% in H1-21
Cairo - Mubasher: GlaxoSmithKline (GSK Egypt) reported an 82.2% year-on-year (YoY) drop in its consolidated net profits to EGP 20.63 million in the first half (H1) of 2021, compared to EGP 115.96 million, including minority shareholders' rights.  …
Financial Results
The company will spin off its consumer healthcare business
28 July 2021 05:40 PM GSK Egypt hires Grant Thornton to assess consumer healthcare assets
Cairo - Mubasher: The board of directors of GlaxoSmithKline (GSK Egypt) decided to hire Grant Thornton Egypt as an independent financial advisor to assess the fair value (FV) of its intangible and movable consumer healthcare assets, excluding …
Corporate Actions
A new company focused on consumer health products will be established
27 July 2021 01:08 PM GSK Egypt to spin off consumer healthcare business
Cairo - Mubasher: GlaxoSmithKline (GSK Egypt) announced that GlaxoSmithKline plc, listed on the London Stock Exchange LSE), will separate its pharmaceuticals and vaccines business from its consumer healthcare business globally and establish two …
Corporate Actions
GSK Egypt achieved net profits of EGP 28.13 million in 2020
27 May 2021 00:22 PM GSK Egypt's shareholders approve EGP 0.5/shr dividend for 2020
Cairo – Mubasher: The ordinary general meeting (OGM) of Glaxo SmithKline (GSK Egypt) approved a cash dividend of EGP 0.50 per share for 2020. The shareholders also approved increasing the number of board members to nine and forming a committee to …
General Assembly
The cost of sales increased to EGP 1.2 billion
31 March 2021 01:38 PM GSK Egypt's profit slides 80% in 2020; dividends proposed
Cairo – Mubasher: The consolidated net profits of Glaxo SmithKline (GSK Egypt) plummeted by 80% year-on-year (YoY) to EGP 28.13 million in 2020, compared to EGP 142.6 million in 2019, excluding minority shareholders’ rights. The profits …
Cash Dividends
The majority shareholder is currently not willing to sell its stake in the company.
15 March 2021 11:04 AM GSK Egypt rejects due diligence request from ACDIMA
Cairo – Mubasher: The board of directors of Glaxo SmithKline (GSK Egypt) has rejected a request from the Arab Company for Drug Industries & Medical Appliances (ACDIMA) to conduct due diligence on the company, according to a bourse disclosure on …
Corporate Actions
The majority shareholder is not currently willing to sell any of its shares in the company
14 March 2021 00:11 PM Galxo Group rejects offer to sell shares in GSK Egypt
Cairo – Mubasher: Glaxo SmithKline (GSK Egypt) has received a letter from the Arab Company for Drug Industries & Medical Appliances (ACDIMA) expressing its interest to acquire the majority shareholder’s stake in the company. ACDIMA requested to be …
Mergers and Acquisitions